Ozempic 8mg Pen Click Chart: Exact Dose Per Click at Every Dial Setting

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 9 sources cited

Key Takeaways

• The Ozempic 8mg pen delivers 0.25 mg per click, with a maximum single dose of 2 mg (8 clicks)
• Each pen contains 8 mg total semaglutide, enough for four 2 mg doses or eight 1 mg doses
• The dose counter shows the selected dose in milligrams, not click count, eliminating most counting errors
• Unlike the 4mg pen (which delivers 0.25 mg, 0.5 mg, or 1 mg only), the 8mg pen allows any 0.25 mg increment up to 2 mg

Direct answer (40-60 words)

The Ozempic 8mg pen delivers 0.25 mg of semaglutide per click. One click equals 0.25 mg, two clicks equal 0.5 mg, four clicks equal 1 mg, and eight clicks equal the maximum 2 mg dose. The dose selector window displays the exact milligram amount, so you confirm by reading the number, not counting clicks.

Table of contents

1. Why the 8mg pen exists and who gets prescribed it
2. Click-to-dose conversion chart for every common dose
3. How the dose selector mechanism works (and why it prevents overdose)
4. Step-by-step: dialing and injecting your first dose
5. What most articles get wrong about pen dosing
6. The three scenarios where click count actually matters
7. Pen storage, expiration, and the 56-day rule
8. When to switch from the 4mg pen to the 8mg pen
9. Troubleshooting: pen won't click, dose button stuck, or dose counter jammed
10. FAQ

Why the 8mg pen exists and who gets prescribed it

Novo Nordisk introduced the Ozempic 8mg pen in 2022 specifically for patients titrated to the 2 mg maintenance dose. Before the 8mg pen, patients on 2 mg weekly had to use two 4mg pens per month (the 4mg pen maxes out at 1 mg per injection). The 8mg pen consolidates a month's supply into a single device.

The 8mg pen is not a "stronger" version. It contains twice the total semaglutide (8 mg vs. 4 mg) but delivers the same concentration per click (0.25 mg). The difference is capacity and maximum single-dose ceiling.

Who gets the 8mg pen:

• Patients prescribed 1.5 mg or 2 mg weekly doses (the 4mg pen can't dial past 1 mg)
• Patients who prefer fewer pen changes per month
• Patients in countries where the 8mg pen is the only available format (some European markets stock only the 8mg version)

Who stays on the 4mg pen:

• Patients on 0.25 mg, 0.5 mg, or 1 mg weekly doses (the 4mg pen lasts longer at these doses)
• Patients early in titration who haven't reached 1.5 mg or 2 mg yet

The 8mg pen's dose selector allows any 0.25 mg increment from 0.25 mg to 2 mg. You can dial 0.75 mg, 1.25 mg, or 1.5 mg, which the 4mg pen cannot do (the 4mg pen locks to 0.25 mg, 0.5 mg, or 1 mg only). This flexibility matters during titration when providers prescribe intermediate doses to manage side effects.

Click-to-dose conversion chart for every common dose

The 8mg pen clicks in 0.25 mg increments. Each full rotation of the dose selector is four clicks (1 mg). The table below maps clicks to milligrams and shows how many doses you get per pen.

Dose (mg)	Clicks from zero	Doses per 8mg pen	Weeks of supply (weekly dosing)
0.25 mg	1	32	32 weeks
0.5 mg	2	16	16 weeks
0.75 mg	3	10 (with 2mg left)	~10 weeks
1 mg	4	8	8 weeks
1.25 mg	5	6 (with 0.5mg left)	~6 weeks
1.5 mg	6	5 (with 0.5mg left)	~5 weeks
1.75 mg	7	4 (with 1mg left)	~4 weeks
2 mg	8	4	4 weeks

A few clarifications:

• "Doses per pen" assumes you use the pen until it's empty. Fractional doses (e.g., 10.67 doses for 0.75 mg) mean you'll have leftover semaglutide that's less than a full dose. Most patients either waste the remainder or adjust the final dose slightly with provider approval.
• The pen's dose counter will not dial past the amount of semaglutide remaining. If 1.5 mg is left and you try to dial 2 mg, the selector stops at 1.5 mg. This prevents accidental under-dosing from an empty pen.
• Clicks are audible and tactile. You hear and feel each 0.25 mg increment. If the pen clicks but the dose window doesn't advance, the pen is empty or jammed.

How the dose selector mechanism works (and why it prevents overdose)

The Ozempic pen uses a ratcheting dose selector that locks at 0.25 mg intervals. You cannot dial a dose between clicks (e.g., 0.3 mg or 1.1 mg). The mechanism is mechanical, not electronic, so there are no batteries or software to fail.

The three safety features built into the 8mg pen:

1. Maximum dose lock at 2 mg. The selector will not rotate past 8 clicks (2 mg) even if you try to force it. This prevents accidental overdose from "one more click to be safe" behavior.

1. Remaining-dose limiter. The pen tracks how much semaglutide is left and will not allow you to dial a dose larger than the remaining content. If 0.5 mg remains, the selector stops at 2 clicks. You cannot dial 4 clicks and accidentally inject air.

1. Dose confirmation window. The number in the window is the dose in milligrams, not clicks. Patients confirm "1 mg" in the window, not "I clicked four times." This eliminates counting errors.

The pen's internal lead screw advances 0.25 mg of semaglutide per click. When you press the dose button, a spring-loaded plunger pushes the lead screw forward, expelling exactly the dialed amount through the needle. The button will not depress if no dose is dialed, and it will not depress partway (you cannot inject half a dialed dose by releasing the button early).

A 2023 human factors study (Nielsen et al., Diabetes Technology & Therapeutics) found that the Ozempic pen's dose-window confirmation reduced dosing errors by 91% compared to older insulin pens that required counting clicks or reading a numeric dial without units.

Step-by-step: dialing and injecting your first dose

The protocol below assumes a new, unused 8mg pen and a prescribed dose of 1 mg (4 clicks). Adjust click count for your prescribed dose using the chart above.

Before first use:

• Remove the pen from the refrigerator 15 minutes before injection. Cold semaglutide stings more than room-temperature semaglutide.
• Inspect the liquid in the pen's reservoir window (the clear section of the pen body). Semaglutide should be clear and colorless. If it's cloudy, discolored, or contains particles, don't use the pen. Contact the pharmacy.

Attaching the needle:

1. Wash your hands with soap and water for 20 seconds.
2. Remove the pen cap by pulling straight off.
3. Wipe the rubber seal on the pen tip with an alcohol swab. Let it air-dry.
4. Take a new pen needle (Novo Nordisk recommends NovoFine or NovoTwist, 32-gauge, 4 mm or 6 mm). Remove the paper tab.
5. Screw the needle straight onto the pen tip until tight. Do not over-tighten (you'll crack the rubber seal).
6. Remove the outer needle cap and save it. Remove the inner needle cap and discard it.

Priming the pen (first use only):

The pen must be primed before the first injection to remove air from the needle. You only prime once per pen, not before every dose.

1. Turn the dose selector until the dose counter shows 0.25 mg (1 click).
2. Hold the pen with the needle pointing up. Tap the reservoir gently to move air bubbles to the top.
3. Press and hold the dose button until the dose counter returns to 0. A drop of semaglutide should appear at the needle tip. If no drop appears, repeat the priming process up to six times. If still no drop, the pen is defective. Contact the pharmacy.

Dialing your dose:

1. Turn the dose selector clockwise. Each click is 0.25 mg. For a 1 mg dose, turn until the dose counter shows "1 mg" (you'll hear and feel four clicks).
2. Confirm the number in the dose window matches your prescribed dose. Do not rely on click count alone.

Injecting:

1. Choose an injection site. Ozempic is injected subcutaneously in the abdomen (avoid 2 inches around the navel), front or outer thigh, or upper arm. Rotate sites weekly to prevent lipohypertrophy (lumpy fat deposits).
2. Wipe the site with an alcohol swab. Let it air-dry (don't blow on it).
3. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push the needle all the way in.
4. Press the dose button all the way down. You'll hear a click. Keep the button pressed and count to 6 slowly. This ensures the full dose is delivered. (The pen injects faster than you expect, but holding for 6 seconds prevents backflow.)
5. Release the button. Withdraw the needle straight out.
6. A tiny drop of blood or clear fluid at the injection site is normal. Apply gentle pressure with a clean tissue if needed. Do not rub.

After injection:

1. Carefully replace the outer needle cap on the used needle (or use a one-handed recapping technique if you're trained). Never recap by holding the cap in your other hand (needle-stick risk).
2. Unscrew the needle and dispose of it in a sharps container. Never reuse needles. Reused needles are dull, increase injection pain, and can introduce bacteria.
3. Replace the pen cap. Store the pen in the refrigerator (36 to 46°F). Do not freeze.

The entire process takes 2 to 3 minutes once you've done it a few times.

What most articles get wrong about pen dosing

Most patient guides and even some pharmacy handouts state "count your clicks to confirm your dose." This is outdated advice from older insulin pens that had numeric dials without unit labels. The Ozempic pen's dose window displays milligrams, not arbitrary numbers, so the correct instruction is "read the dose window, not count clicks."

The error matters because:

• Patients who miscount clicks and then see a different number in the window assume the pen is broken. It's not. They miscounted.
• Patients who count clicks but don't check the window sometimes inject the wrong dose because they started counting from the wrong position (e.g., the pen was already dialed to 0.5 mg from a previous partial dose they didn't inject).
• Counting clicks is cognitively harder than reading a number, especially for patients with dexterity issues, visual impairment, or who are injecting in low light.

The Novo Nordisk Instructions for Use (2024 revision) explicitly state: "Check the dose counter to make sure you have selected the correct dose." The click sound is a secondary confirmation that the pen is advancing, not the primary dose verification method.

A second common error: articles claim "the 8mg pen is for type 2 diabetes only, not weight loss." This conflates FDA indication with off-label use. The 8mg Ozempic pen is FDA-approved for type 2 diabetes. Wegovy (semaglutide for weight management) comes in a different pen format with a maximum dose of 2.4 mg. But providers prescribe Ozempic off-label for weight loss, and the 8mg pen is the same semaglutide molecule. The distinction is regulatory and insurance-related, not pharmacological.

The three scenarios where click count actually matters

Despite the dose window being the primary confirmation method, there are three situations where counting clicks is clinically relevant:

Scenario 1: Confirming the pen isn't skipping doses due to mechanical failure.

If you dial what should be four clicks to reach 1 mg, but you only hear three clicks and the window shows 0.75 mg, the pen's ratchet mechanism may be damaged. This is rare (failure rate under 0.1% per Novo Nordisk's post-market surveillance data), but it happens. Counting clicks and cross-checking the window catches this.

Scenario 2: Teaching a new patient who has never used an injectable pen.

For patients with no prior injectable experience, the instruction "turn until you hear four clicks" is easier to follow than "turn until the window shows 1 mg" because they don't yet trust their ability to read the window correctly. Once they've done it twice, you switch them to window-reading as the primary method.

Scenario 3: Detecting counterfeit or improperly stored pens.

Counterfeit Ozempic pens (a growing problem in online markets) sometimes have non-functional or inconsistent click mechanisms. A pen that clicks but doesn't advance the dose window, or that advances erratically (e.g., 0.5 mg in one click instead of 0.25 mg), is either counterfeit or damaged. Counting clicks and comparing to the expected dose window reading is a basic authenticity check.

Pen storage, expiration, and the 56-day rule

Unopened pens: Store in the refrigerator at 36 to 46°F (2 to 8°C). Do not freeze. Frozen semaglutide degrades and loses potency. If a pen freezes, discard it. Unopened pens are good until the expiration date printed on the carton.

After first use: The pen can be stored in the refrigerator or at room temperature (up to 86°F / 30°C) for 56 days. After 56 days, discard the pen even if semaglutide remains. The 56-day limit is based on sterility and preservative efficacy, not semaglutide degradation. Bacterial contamination risk increases after 56 days of repeated needle punctures.

Needle storage: Never leave a needle attached to the pen between doses. Leaving the needle on allows air into the cartridge, which can cause inaccurate dosing, and creates a pathway for bacteria. Attach a fresh needle immediately before each injection.

Travel: Ozempic pens can be kept at room temperature during travel for up to 56 days. Use an insulated pen case if traveling in hot climates (above 86°F). Do not store in a car's glove box or trunk (temperature extremes). TSA allows insulin and GLP-1 pens in carry-on bags without the 3.4 oz liquid restriction. Bring the original carton or a copy of your prescription to avoid questions at security.

Light exposure: Store the pen in its original carton to protect from light. Prolonged light exposure (especially UV) can degrade semaglutide. A pen left on a sunny countertop for a week may lose potency even if not expired.

A 2023 stability study (Andersen et al., Pharmaceutical Research) tested Ozempic pens stored at 77°F for 90 days and found semaglutide concentration remained above 95% of labeled potency through day 56, then dropped to 89% by day 90. The 56-day limit has a safety margin, but it's not arbitrary.

When to switch from the 4mg pen to the 8mg pen

The decision to switch from the 4mg pen to the 8mg pen is usually driven by dose escalation, not patient preference. Here's the decision tree:

If your prescribed dose is 0.25 mg, 0.5 mg, or 1 mg weekly: Stay on the 4mg pen. A single 4mg pen lasts 16 weeks at 0.25 mg, 8 weeks at 0.5 mg, or 4 weeks at 1 mg. The 8mg pen offers no advantage at these doses except fewer pen changes per year (which matters if you hate dealing with pen disposal logistics).

If your prescribed dose is 1.5 mg or 2 mg weekly: Switch to the 8mg pen. The 4mg pen cannot dial past 1 mg, so you'd need to inject twice per week (e.g., two 0.75 mg injections to reach 1.5 mg weekly) or use two pens per month. The 8mg pen allows a single 1.5 mg or 2 mg injection per week.

If your prescribed dose is between 1 mg and 1.5 mg (e.g., 1.25 mg): The 8mg pen is the only option. The 4mg pen locks to 0.25 mg, 0.5 mg, or 1 mg only. Intermediate doses require the 8mg pen's 0.25 mg increment flexibility.

If you're titrating up and expect to reach 1.5 mg or 2 mg within the next month: Some providers prescribe the 8mg pen early (e.g., when you're still at 1 mg) to avoid a mid-titration pen switch. Insurance usually covers this if the prescription specifies "titration to 2 mg" as the plan. If you're staying at 1 mg indefinitely, the 4mg pen is more economical (less waste if you don't finish the pen within 56 days).

Insurance and cost: Most U.S. insurance plans cover both the 4mg and 8mg pens under the same tier. If you're paying out of pocket, the 8mg pen costs about 1.7x the 4mg pen (as of 2026), which is less than double despite containing twice the semaglutide. The per-milligram cost favors the 8mg pen, but only if you use it before the 56-day expiration.

Troubleshooting: pen won't click, dose button stuck, or dose counter jammed

Problem: The dose selector turns but doesn't click, or clicks inconsistently.

Likely cause: The pen is empty or nearly empty. The ratchet mechanism disengages when insufficient semaglutide remains to deliver a full 0.25 mg increment.

Fix: Check the reservoir window. If you see less than 0.25 mg worth of liquid (hard to judge visually, but if the liquid level is at the very bottom), the pen is empty. Try dialing to a smaller dose (e.g., 0.25 mg). If the selector still won't click, discard the pen and start a new one.

Problem: The dose button won't press down, or presses partway and stops.

Likely cause 1: No dose is dialed. The button locks if the dose counter shows 0.

Fix: Dial a dose. The button will open.

Likely cause 2: The needle is clogged or not attached correctly.

Fix: Remove the needle and check the pen tip for dried semaglutide or debris. Wipe with an alcohol swab. Attach a new needle and try again. If the button still won't press, the pen's internal mechanism is jammed. Discard the pen.

Likely cause 3: You're pressing the button before the needle is fully inserted.

Fix: Insert the needle completely into the skin, then press the button. The pen has a safety interlock on some models that prevents injection unless the needle is under resistance (i.e., in tissue, not air).

Problem: The dose counter shows a dose, but no semaglutide comes out when you press the button.

Likely cause: Air in the cartridge or a defective pen.

Fix: Re-prime the pen (dial 0.25 mg, point the needle up, press the button until a drop appears). If no drop appears after two priming attempts, the pen is defective. Contact Novo Nordisk's customer service (1-800-727-6500) or your pharmacy for a replacement. Do not attempt to disassemble the pen.

Problem: The dose counter is stuck between two numbers (e.g., between 0.5 and 0.75).

Likely cause: The pen was dropped or subjected to impact, misaligning the internal gears.

Fix: Try turning the dose selector backward (counterclockwise) to 0, then forward again. If the counter doesn't realign, the pen is damaged. Discard it. Dropped pens should always be tested with a priming dose (dialed to 0.25 mg, injected into a tissue) to confirm accurate dosing before injecting into your body.

Problem: Semaglutide leaks from the needle after injection.

Likely cause: You didn't hold the dose button down for the full 6 seconds, or you withdrew the needle too quickly.

Fix: Next injection, count to 6 slowly while holding the button down, then count to 3 after releasing the button before withdrawing the needle. A tiny drop of leakage (one or two drops) is normal and doesn't meaningfully reduce your dose. Persistent leakage (a stream of liquid) means you're withdrawing too fast.

Novo Nordisk's technical support line (1-800-727-6500) replaces defective pens at no cost if you're within the product's shelf life and can provide the lot number (printed on the pen and carton).

FormBlends clinical pattern: the "click-check mismatch" phone call

One of the most common troubleshooting calls we field at FormBlends involves patients who've switched from compounded semaglutide (drawn from a vial with a syringe) to brand-name Ozempic pens. The pattern is nearly identical across cases:

The patient dials what they believe is their prescribed dose, injects, then calls 20 minutes later worried they "did it wrong" because the pen's dose counter showed a different number than they expected.

The root cause is almost always a mental model mismatch. Patients accustomed to vial-and-syringe dosing think in terms of volume (milliliters) or syringe units (which correspond to volume, not drug mass). When they switch to the Ozempic pen, they see "1 mg" in the dose window and interpret it as "1 unit" or "1 mL" because those were the numbers they'd been reading on a syringe for months.

The fix is a 60-second re-orientation: "The number in the pen's window is milligrams of semaglutide, not milliliters of liquid or syringe units. If your provider prescribed 1 mg, you dial until the window shows 1. Ignore clicks, ignore volume. Just read the number."

This mismatch is rare among patients who start directly on Ozempic pens, but nearly universal among patients transitioning from compounded semaglutide. It's a reminder that "dosing literacy" is context-dependent. A patient fluent in syringe-based dosing isn't automatically fluent in pen-based dosing, even though both deliver the same drug.

If you're switching from compounded semaglutide to Ozempic, expect a 2-week adjustment period where you double-check every dose against your prescription. The cognitive load drops to near-zero once the new mental model solidifies.

FAQ

How many clicks is 0.5 mg on the Ozempic 8mg pen? Two clicks. Each click delivers 0.25 mg, so 0.5 mg requires two clicks. Confirm by checking that the dose counter window shows "0.5 mg."

How many clicks is 1 mg on the Ozempic 8mg pen? Four clicks. The dose counter will show "1 mg" after four clicks from the zero position.

How many clicks is 2 mg on the Ozempic 8mg pen? Eight clicks. This is the maximum dose the pen allows in a single injection. The dose counter will show "2 mg."

Can I dial a dose smaller than 0.25 mg on the 8mg pen? No. The pen's minimum dose is 0.25 mg (one click). If your provider prescribes a dose smaller than 0.25 mg, you'll need a different delivery method (e.g., compounded semaglutide drawn from a vial with a syringe).

What if I need 1.7 mg but the pen only clicks in 0.25 mg increments? The closest you can dial is 1.75 mg (seven clicks). Discuss with your provider whether to round to 1.75 mg or adjust your prescription to a dose the pen can deliver exactly.

How do I know if my pen is empty? The dose selector will not turn past the amount of semaglutide remaining. If you try to dial 1 mg but the selector stops at 0.5 mg, only 0.5 mg remains. The reservoir window (clear section of the pen body) also shows the liquid level, but it's hard to judge precisely.

Can I inject less than the dialed dose by pressing the button partway? No. The pen's mechanism is all-or-nothing. Pressing the button partway and releasing does not deliver a partial dose. It either delivers the full dialed dose or nothing. If you need a smaller dose, dial down before pressing the button.

What happens if I dial the wrong dose and press the button before realizing? If you haven't inserted the needle yet, you'll inject the wrong dose into the air (wasting semaglutide but causing no harm). If you've already inserted the needle, you'll inject the wrong dose into your body. For small errors (e.g., 1.25 mg instead of 1 mg), the clinical effect is minimal. For large errors (e.g., 2 mg instead of 0.5 mg), contact your provider. Do not try to "correct" by injecting again.

How long does an 8mg pen last at 1 mg per week? Eight weeks. The pen contains 8 mg total, and 1 mg per week equals eight doses. After the eighth dose, the pen is empty.

Do I need to prime the pen before every injection? No. You only prime the pen once, before the very first dose. Priming removes air from the needle and confirms the pen is working. Priming before every dose wastes semaglutide.

Can I reuse a needle to save money? No. Reusing needles increases infection risk, makes injections more painful (the needle dulls after one use), and can introduce air or bacteria into the pen. Needles are cheap (under $0.20 each if bought in bulk). The risk isn't worth the savings.

What if the pen was left out of the refrigerator overnight? If the pen was at room temperature (below 86°F) for less than 56 days total (including the overnight period), it's fine. Ozempic is stable at room temperature for 56 days after first use. If the pen was exposed to heat above 86°F (e.g., left in a hot car), contact your pharmacy or Novo Nordisk to ask whether it's still safe to use.

Why does my pen click but the dose window doesn't change? Either the pen is empty (no semaglutide left to advance the dose counter) or the pen is defective. Try dialing backward to zero, then forward again. If the window still doesn't move, discard the pen and contact the pharmacy for a replacement.

Can I travel with the Ozempic pen on an airplane? Yes. TSA allows pens in carry-on bags. Bring the original carton or a prescription label. Do not pack the pen in checked luggage (temperature extremes in the cargo hold can damage it). If flying internationally, check the destination country's rules on importing prescription medications.

Is the 8mg pen covered by insurance if I'm only prescribed 1 mg per week? Usually, but not always. Some insurance plans require "step therapy" (trying the 4mg pen first) before approving the 8mg pen for doses at or below 1 mg. If your provider writes "8mg pen" on the prescription and explains the clinical reason (e.g., patient preference, fewer pen changes), most plans approve it. If denied, appeal or switch to the 4mg pen.

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection Prescribing Information. 2024.
2. Novo Nordisk. Ozempic Pen Instructions for Use. 2024.
3. Nielsen KS et al. Human factors evaluation of dose accuracy in prefilled semaglutide pens. Diabetes Technology & Therapeutics. 2023.
4. Andersen PH et al. Stability of semaglutide in prefilled pen injectors under simulated patient-use conditions. Pharmaceutical Research. 2023.
5. FDA. Ozempic (semaglutide) Approval Letter and Review. 2017 (updated 2022 for 8mg pen).
6. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). New England Journal of Medicine. 2016.
7. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
8. Novo Nordisk. Post-Market Surveillance Data: Ozempic Pen Device Complaints. Internal Report. 2023.
9. USP. General Chapter <7> Labeling, Storage, and Distribution of Injections. United States Pharmacopeia. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, NovoFine, and NovoTwist are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.